Coave Therapeutics
Marie-Anne joined Coave Therapeutics in January 2021 as a project manager. She has a veterinary medicine degree from the National Veterinary School of Toulouse and holds a Ph.D. degree in Neuroscience from Paris University. During her thesis, she used AAV vectors to restore brain cholesterol metabolism in a model of Alzheimer’s disease (AD). In 2014, she joined Animalliance to practice as a veterinarian in experimental research. In 2016, she transitioned to project management and coordinated several research studies on AD, brain aging, and neurodegenerative diseases at Medday Pharmaceuticals.
This person is not in the org chart
This person is not in any offices
Coave Therapeutics
2 followers
Coave Therapeutics develops innovative gene therapy products for rare ophthalmic diseases to preserve visual autonomy in affected patients.